Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jade Ghosn

Showing results (231-240 of 267) with videos related to

Pageof 27
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|July 10, 2024
Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir + Rilpivirine Long-Acting Into European Clinical SettingsCelia Jonsson-Oldenbüttel, Jade Ghosn, Marc van der Valk, et al.
NEJM Evidence|February 6, 2024
Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19José R Arribas, Sanjay Bhagani, Suzana M Lobo, et al.
The Lancet. HIV|June 30, 2022
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort studyJean-Michel Molina, Jade Ghosn, Lambert Assoumou, et al.
JMIR Research Protocols|December 14, 2023
Impact of the COVID-19 Health Crisis on Key Populations at Higher Risk for, or Living With, HIV or Hepatitis C Virus and People Working With These Populations: Multicountry Community-Based Research Study Protocol (EPIC Program)Rosemary M Delabre, Marion Di Ciaccio, Nicolas Lorente, et al.
Nature Communications|November 26, 2022
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severityNikaïa Smith, Céline Possémé, Vincent Bondet, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2022
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort studyMorgane Mailhe, Anne-Lise Beaumont, Michael Thy, et al.
Archives of Sexual Behavior|June 21, 2022
PrEP in the Context of Other HIV Risk Reduction Strategies Among Men Who Have Sex with Men: Results from the Flash! PrEP in Europe SurveyMarion Di Ciaccio, Rosemary M Delabre, Antoine Vilotitch, et al.
Plos Pathogens|September 25, 2015
Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV InfectionAbderaouf Damouche, Thierry Lazure, Véronique Avettand-Fènoël, et al.
Ebiomedicine|May 20, 2022
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccineSéverin Coléon, Aurélie Wiedemann, Mathieu Surénaud, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 3, 2022
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohortJade Ghosn, Delphine Bachelet, Marine Livrozet, et al.
Pageof 27

Showing results (231-240 of 267) with videos related to

Sort By:
Pageof 27
Journal of Acquired Immune Deficiency Syndromes (1999)|July 10, 2024
Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir + Rilpivirine Long-Acting Into European Clinical SettingsCelia Jonsson-Oldenbüttel, Jade Ghosn, Marc van der Valk, et al.
NEJM Evidence|February 6, 2024
Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19José R Arribas, Sanjay Bhagani, Suzana M Lobo, et al.
The Lancet. HIV|June 30, 2022
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort studyJean-Michel Molina, Jade Ghosn, Lambert Assoumou, et al.
JMIR Research Protocols|December 14, 2023
Impact of the COVID-19 Health Crisis on Key Populations at Higher Risk for, or Living With, HIV or Hepatitis C Virus and People Working With These Populations: Multicountry Community-Based Research Study Protocol (EPIC Program)Rosemary M Delabre, Marion Di Ciaccio, Nicolas Lorente, et al.
Nature Communications|November 26, 2022
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severityNikaïa Smith, Céline Possémé, Vincent Bondet, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2022
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort studyMorgane Mailhe, Anne-Lise Beaumont, Michael Thy, et al.
Archives of Sexual Behavior|June 21, 2022
PrEP in the Context of Other HIV Risk Reduction Strategies Among Men Who Have Sex with Men: Results from the Flash! PrEP in Europe SurveyMarion Di Ciaccio, Rosemary M Delabre, Antoine Vilotitch, et al.
Plos Pathogens|September 25, 2015
Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV InfectionAbderaouf Damouche, Thierry Lazure, Véronique Avettand-Fènoël, et al.
Ebiomedicine|May 20, 2022
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccineSéverin Coléon, Aurélie Wiedemann, Mathieu Surénaud, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 3, 2022
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohortJade Ghosn, Delphine Bachelet, Marine Livrozet, et al.
Pageof 27